Why IP lawyers should care about the IRA

Join the Hogan Lovells Life Sciences & Health Care team and guest speaker Henry Hadad, Senior Vice President and Deputy General Counsel of Bristol Myers Squibb, for a discussion on the intellectual property impacts of the Inflation Reduction Act.

We will highlight key areas that the IP function at a pharma or biotech company of any size should consider, including strategies for investments in IP/innovation, license agreement strategies, patent prosecution considerations, what rights to prioritize (and not), litigation strategies, and more.

Click here to watch the recording

Back To Listing